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ABSTRACT
Human La protein is an essential factor in the biology
of both coding and non-coding RNAs. In the
nucleus, La binds primarily to 30 oligoU containing
RNAs, while in the cytoplasm La interacts with an
array of different mRNAs lacking a 30 UUUOH trailer.
An example of the latter is the binding of La to the
IRES domain IV of the hepatitis C virus (HCV) RNA,
which is associated with viral translation stimula-
tion. By systematic biophysical investigations, we
have found that La binds to domain IV using an
RNA recognition that is quite distinct from its
mode of binding to RNAs with a 30 UUUOH trailer:
although the La motif and first RNA recognition
motif (RRM1) are sufficient for high-affinity binding
to 30 oligoU, recognition of HCV domain IV requires
the La motif and RRM1 to work in concert with the
atypical RRM2 which has not previously been shown
to have a significant role in RNA binding. This new
mode of binding does not appear sequence specific,
but recognizes structural features of the RNA, in par-
ticular a double-stranded stem flanked by single-
stranded extensions. These findings pave the way
for a better understanding of the role of La in viral
translation initiation.
INTRODUCTION
La is an exceedingly abundant protein functioning in vari-
ous intracellular processes involving RNA. Originally
identiﬁed as an autoantigen in patients affected by the
rheumatic diseases Sjo¨gren’s syndrome and systemic
lupus erythematosus, La was found ubiquitously ex-
pressed throughout eukaryotes (1). Within the nucleus,
La associates with all newly synthesized RNA polymerase
(pol) III transcripts, including precursors to 5S rRNA and
tRNAs, as well as a subset of pol II small nuclear and
nucleolar RNA intermediates, by binding speciﬁcally to
the common (U)n-OH moiety present at the 3
0 termini of
these RNAs (1–4). La is a key player in the metabolism,
maturation, processing, folding and subcellular localiza-
tion of these regulatory non-coding RNA precursors,
with the protection of the 30 ends from exonuclease cleav-
age being the best-characterized role of La from yeasts to
humans (1,2,5–8). The ubiquitous nature of this function
relates to a highly conserved region that maps to the
N-terminal half of the human protein and contains an
elaborated winged-helix domain, the La motif (LaM),
neighbouring an RNA recognition motif, the RRM1
(Figure 1) (1,2,9–11). The LaM and RRM1 perform as a
single RNA-binding unit (recently re-named the ‘La
module’) to recognize 30 UUUOH single-stranded (ss)
RNA sequences and structural studies have delineated how
these domains are conﬁgured to achieve high-speciﬁcity
binding to 30 oligoU RNA (Figure 1) (12–14). In particu-
lar, both domains make speciﬁc contacts with the 30
oligoU sequence, inducing it to fold into a conformation
that stacks the third- or fourth-last U onto the terminal
nucleotide base (Figure 1). The primary contacts for spe-
ciﬁcity are made by the LaM with the 20- and 30-hydoxyl
groups of the terminal nucleotide and by both domains
with the penultimate U, which is splayed out in the con-
formation adopted by the bound RNA (12–14).
This mode of RNA binding is unusual and intriguing
since it uses neither of the canonical RNA-binding
surfaces—the winged-helix of the LaM or the b-sheet
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surface of RRM1—which may therefore be potentially
available to interact with other portions of larger RNA
ligands. Indeed, recognition of 30 oligoU sequences
appears to be only one facet of the RNA interactions made
by La and recent investigations of the functional inter-
action with pre-tRNA targets suggest that as well as
clamping onto the 30 oligoU trailer the protein establishes
additional points of contact with the RNA (15–17).
However the complexity and diversity of the RNA-
binding repertoire of La does not stop here, as in some
cases La–RNA interactions occur that appear to be
entirely independent of binding to a 30 oligoU trailer.
This is exempliﬁed by the cytoplasmic role of human La
protein (hLa) where it can associate with internal
ribosome entry sites (IRES) found in a subset of cellular
mRNAs or in the positive-sense RNA genomes of viruses
such as poliovirus, human immunodeﬁciency virus (HIV)
or hepatitis C virus (HCV) (18–26). Mostly, the hLa–
IRES interaction appears to augment translation, although
the molecular mechanism of how this is achieved remain
obscure, in part because the details of the hLa–RNA
binding have not been elucidated.
Most work on hLa–IRES interactions has been done
with HCV, where the stimulatory role of hLa in viral
mRNA translation has been linked to a direct interaction
between hLa and the HCV IRES element (19,21–23), in
particular involving the IRES domain IV in the vicinity of
the AUG start codon (Figure 1) (21,22). Signiﬁcantly, this
RNA contains neither the free 30 end nor the terminal
oligoU sequences that are invariably found in the nuclear
pol III nascent transcripts and would activate the canon-
ical and well-characterized 30-termini recognition
(9,12,13).
The key question of how exactly hLa recognizes ‘internal’
structured RNA sequences lacking a 30 oligoU trailer has
yet to be addressed. It has been suggested that the
C-terminal half of the human La protein, which contains
a second RRM domain (RRM2) followed by an unstruc-
tured stretch of polypeptide (27) punctuated by a short
basic motif (SBM) (Figure 1A), may be implicated in
interactions with mRNAs rather than pre-tRNAs
(2,21,22,28). However, deﬁnitive evidence for a contribu-
tion of this region to the RNA-binding properties of hLa
has yet to be produced. Although some early studies
based on deletion mutagenesis experiments suggested such
a role for RRM2 (23,29), these were performed used a
truncated form of the domain that may have been mis-
folded and therefore prone to artefacts (27). Notably, the
functional signiﬁcance of the C-terminal half of La
proteins has been clouded by the fact that they display
a lower degree of conservation varying in both size and
sequence between species; neither the second RRM nor
the SBM, which could potentially confer additional
RNA-binding capability to hLa, are found in the yeast
proteins (27,30) (Figure 1).
To shed new light on the versatility of La–RNA inter-
actions and the molecular basis of La’s role in mRNA
translation, we set out to analyse in detail the ability of
Figure 1. Details of the human La protein and the HCV IRES domain. (A) Domain organization of human La showing the La motif (LaM) and
RRM1 (forming the La module), the RRM2, the nuclear retention element (NRE), the Short Basic Motif (SBM) and nuclear localization signal
(NLS). (B) Structured domains of human La, depicting the crystal structure of the La module in complex with a 30 oligoU ssRNA (PDB ID 2VOP)
and the solution structure of the isolated RRM2 (PDB ID 1OWX). A dotted grey line denotes the linker between the RRM1 and RRM2. Red stars
indicate the canonical RNA-binding surfaces on the three domains. (C) Schematic representation of the secondary structure elements and domains of
the HCV IRES. The domain fragment used in biophysical experiments (domain IV) is highlighted. The black arrowhead indicates the base that was
mutated from U to A in our experiments.
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hLa to bind to 30 oligoU-deﬁcient RNA molecules. Steered
by the current knowledge (21,22), for these investigations
we chose a 27-nt RNA fragment comprising domain IV of
HCV IRES (residues 330–356) that includes the AUG
start codon and spans part of the core-coding sequence
(Figure 1) (31,32). An array of quantitative biophysical
and biochemical techniques were employed to examine
the interaction between this RNA fragment and hLa;
several structure-based variants of HCV IRES domain
IV and deletion mutants of hLa were used to fully
dissect the interaction. Unexpectedly, these experiments
revealed a mode of RNA recognition for hLa that
results from the synergistic action of all three structured
domains—the LaM, RRM1 and RRM2—and is therefore
quite distinct from the interaction hLa makes with 30
oligoU sequences. By RNA mutagenesis analysis we also
demonstrated that this alternative mode of binding by hLa
involves a sequence-independent recognition of a short
double-stranded stretch ﬂanked by a single-stranded ex-
tension, which is in line with a more general chaperone
role for La in mRNA-related activities. Our results there-
fore attest to the remarkable adaptability of the hLa
protein and provide the ﬁrst evidence of RNA contacts
by the La RRM2 domain, which was previously shown
not to be involved in binding 30 UUUOH sequences and
pre-tRNA ligands.
MATERIALS AND METHODS
Plasmid construction
A variety of plasmids encoding the full-length human La
protein and several deletion mutants were used to produce
recombinant proteins. La(1–408) and La(1–194) were
cloned as reported previously (27). The fragment contain-
ing the three structured domains, La(4–325), and the
tandemRRM construct, La(105–325), were ampliﬁed from
pET-La1–408 using PCR and subcloned into a modiﬁed
pETM-11 vector to include a TEV NIa protease (TEVpro)
cleavable N-terminal His6-tag. La(1–354) was cloned into
an in-house modiﬁed pET30 vector, so as to have a
TEVpro following the N-terminal His6-tag. La(1–229)
was cloned in a pET-30 vector using a LIC methodology
(Novagen) (33).
Protein expression and puriﬁcation
All the La proteins were expressed in Escherichia coli
strain Rosetta II at 37C in rich media with induction by
1mM IPTG (isopropyl b-D-thiogalactoside). Expressions
were also performed in minimal media containing 0.8 g/l
15-ammonium chloride for La(1–194) and La(4–325) and
in minimal media containing 0.8 g/l 15N-ammonium
chloride, 2 g/l 13C glucose and 95% D2O for La(4–325).
La(1–408) and La(1–194) were expressed and puriﬁed as
described before (27). Cell pellets containing La(4–325),
La(1–354), La(105–325) or La(1–229) were lysed by son-
ication in 50mM Tris, 300mM NaCl, 10mM imidazole,
5% glycerol, pH 8.0, 2mM PMSF (phenylmetha-
nesulfonyl ﬂuoride), pH 8.0. Lysates were clariﬁed by cen-
trifugation and applied to 5ml HisTrap columns (GE
Healthcare) with protein elution performed over a
gradient of 20–300mM imidazole. The His6-tag was
cleaved from La(4–325) by incubating the protein over-
night with TEVpro [at TEVpro:La(4–325) molar ratio of
1:50] at 30C in 50mM Tris, 100mM NaCl, 1mM DTT
(dithiothreitol), pH 8. The cleaved tags, the His-tagged
TEVpro and any undigested product from the reaction
mixture were removed by a further round of puriﬁcation
on a Ni–NTA column (Qiagen). The La proteins were
then loaded on a 5ml Hi-Trap heparin column, mainly
to eliminate nucleic acids contaminants, and eluted
with a linear 0–2 M KCl gradient. Following overnight
dialysis, ﬁnal puriﬁcation was performed by gel ﬁltra-
tion on a Superdex
TM
75 10/300 GL column run at
0.5ml/min in 20mM Tris, 100mM KCl, 0.2mM EDTA
(ethylenediaminetetraacetic acid), 1mM DTT, pH 7.25.
Protein concentrations were calculated based upon the
near-UV absorption (e280) using theoretical extinction co-
efﬁcients derived from ExPASY (34).
RNA sample preparation
RNA 4-nt oligoU (50-UUUU-30) was synthesized and gel
puriﬁed by Dharmacon Inc. Domain IV of HCV IRES
and the following mutants were synthesized and gel
puriﬁed by IBA GmbH (Go¨ttingen, Germany): IV, a
27-mer of sequence 50-AGACCGUGCACCAUGAGCA
CGAAUCCA-30, corresponding to the entire domain IV
(encompassing residues 330–356) with the 30 U (U356)
mutated to A; IVOMe, bearing a methyl group at the
30-OH; IV30ext of sequence 50-CGUGCACCAUGAGCA
CGAAUCCA-30; IV50ext of sequence 50-AGACCGUGC
ACCAUGAGCACG-30; 27-mer ssRNA of sequence
50-ACCUAACCACCACUACCACCUCCCACA-30. The
RNA oligo IVUUUU, a mutant version of the domain IV
in which the ﬁrst 3 nt were changed to C and the last three
to U (50-CCCCCGUGCACCAUGAGCACGAAUUUU
-30) was purchased from Primm srl (Milan, Italy).
Domain IV and two mutants thereof were prepared by
in vitro T7 polymerase transcription: IVhalves, where the
two halves of the domain IV RNA, 50-AGACCGUGUG
CACCA-30 and 50-UGAGCACGAAUCCA-30, were
made separately and then annealed together (see below);
IVlowerSL, containing only the lower stem-loop of the
domain IV, of sequence 50-CGUGCACCAUGAGCAC
G-30. The 22-mer RNA oligo (22-mer structRNA) of
sequence 50-CACCUAUAUAGUUAUAUAAUAA-30
was a kind gift from Ian Taylor, NIMR.
For in vitro transcription, large-scale homogeneous
RNA production was performed as described earlier (35).
Brieﬂy, a 50 hammerhead ribozyme and target RNA se-
quence(s) were cloned between the T7 promoter and
hepatitis d ribozyme site in the plasmid pUC119dv,
using XbaI and PstI restriction sites (36). The ribozyme
construct was linearized with HindIII and transcribed in
a standard large-scale T7 polymerase reaction at 10–
14ml scale. The reaction mix was then annealed for
10min at 65C, slow cooled to 55C and held at this
temperature for 30min. Product RNAs were puriﬁed on
an 8M urea 10% polyacrylamide denaturing gel and
then eluted with PAGE elution buffer, 0.5M
ammonium acetate, 10mM magnesium acetate, 1mM
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EDTA, 0.1% SDS (sodium dodecyl sulphate). Following
ethanol precipitation, the RNA was extensively dialysed
in 20mM Tris, 100mM KCl, 10mM MgCl2, 1mM DTT,
pH 7.25 and then concentrated using centrifugal concen-
trators (Vivaspin).
Solutions of IV, IVOMe, IV30ext, IV50ext, IVUUUU, 22-mer
structRNA, 27-mer ssRNA and 4-nt oligoU were
prepared by solubilizing the oligonucleotides in 20mM
Tris, 100mM KCl, 10mM MgCl2, 1mM DTT, pH 7.25;
the RNAs were annealed by heating at 95C for several
minutes followed by slow cooling to room temperature
(>4 h). The IVhalves RNA was prepared by mixing
together equal concentrations of the two complementary
RNAs and annealing the resulting solution as described
before. The concentration of the dissolved oligonucleo-
tides was evaluated by UV measurement at 95C, using
the molar extinction coefﬁcients at 260 nm calculated by
the nearest-neighbour model (37).
Nuclear magnetic resonance spectroscopy
Nuclear Magnetic Resonance (NMR) samples of
15N-labelled La(1–194) and La(4–325) and
2H/15N/13C-labelled La(4–325) were prepared by dialysing
the puriﬁed protein against 20mM Tris, 100mM KCl,
1mM DTT, pH 7.25. NMR spectra were recorded at
298K on a Varian Inova spectrometer operating at 18.8
T and on a Bruker Avance spectrometer operating at 16.4
T both equipped with triple resonance cryoprobes. The
spectra were processed using NMRPipe/NMRDraw (38)
and analysed using NEASY (39).
Two sets of NMR titration experiments were performed
by adding increasing amounts of unlabeled IV RNA
solution into a sample containing 15N-labelled La(1–194)
or 2H/15N/13C-labelled La(4–325). 1H-15N HSQC or
1H-15N TROSY-HSQC spectra were recorded at
protein:IV RNA molar ratio of 1:0, 1:0.3, 1:0.6, 1:1.0
1:1.3.
A 2H/15N/13C-labelled La(4–325) sample was used to
collect 1H-15N TROSY-HSQC, TROSY-HNCA, TROSY-
HNCACB, TROSY-HNCOCACB and TROSY-HNCO, to
yield an almost complete backbone assignment of the
apo protein (deposited to BMRB, accession number
17 878). To this sample was then added IV RNA to a
ﬁnal protein:RNA molar ratio of 1:1.2 and 1H-15N
TROSY-HSQC, TROSY-HNCA, TROSY-HNCOCA
and TROSY-HNCO were acquired on the complex.
Chemical shift variations were determined where
possible by comparing 3D spectra of the apo La(4–325)
protein with those of La(4–325) complexed with HCV
RNA. When the poor spectral quality and/or instability
of the complex precluded the unambiguous identiﬁcation
of resonance signals in the bound state, the analysis was
conducted as follows: (i) in regions of reasonable spectral
clarity, signals were transferred to the resonances of the
complex that would have the smallest chemical shift vari-
ation (dAV); (ii) where the peak unambiguously moved
but severe spectral overlap prevented a clear identiﬁcation
of the nearest neighbour, the chemical shift variations
were broadly classiﬁed as ‘not quantiﬁed’; (iii) resonances
that clearly disappeared because of line broadening were
classiﬁed as ‘disappearing signals’; (iv) several resonances
were left unassigned or unclear (Supplementary Figure
S2C).
The weighted average of 15N and 1HN chemical shift
variation (dAV) was calculated as follows (9):
AV ¼
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Chemical shift variations upon RNA binding were divided
in ﬁve major categories: weak 0.035dAV 0.06;
medium 0.06<dAV 0.1; strong dAV> 0.1; not
quantiﬁed; and signals that disappear upon interaction
(Supplementary Figure S2C).
Isothermal titration calorimetry
For most experiments protein and RNA solutions were
prepared in 20mM Tris, 100mM KCl, 10mM MgCl2,
1mM DTT, pH 7.25 (exceptions are noted in the text).
Experiments in which the La proteins were titrated with
RNA solutions were performed at 298K using an
Isothermal Titration Calorimetry (ITC)-200 microcalori-
meter from Microcal (GE Healthcare) following the
standard procedure reported previously (40). In each titra-
tion twenty injections of 2 ml each of a RNA solution, at a
concentration of 120–140mM, were added into a 15 mM
protein solution. A spacing of 180 s between each injection
was applied to enable the system to reach the equilibrium.
Heat produced by titrant dilution was veriﬁed to be neg-
ligible by a control experiment, titrating into buffer alone,
under the same conditions. Integrated heat data obtained
for the titrations corrected for heats of dilution were ﬁtted
using a non-linear least-squares minimization algorithm
to a theoretical titration curve, using the MicroCal-
Origin 7.0 software package. H (reaction enthalpy
change in kJ/mol), Kb (equilibrium binding constant in
per molar) and n (molar ratio between the protein and
the RNA in the complex) were the ﬁtting parameters.
The reaction entropy was calculated using the relation-
ships G=RT·lnKb (R=8.314 J/(mol·K), T 298K)
and G=HTDS.
Where explicitly speciﬁed in the text, ITC experiments
on La(4–325) were repeated in absence of MgCl2: 20mM
Tris, 100mM KCl, 1mM DTT, pH 7.25; or in absence of
MgCl2 and varying KCl concentrations (115, 150, 200mM
respectively).
Circular dichroism spectroscopy
Circular Dichroism (CD) spectra of RNA and protein
samples were recorded on the Applied Photophysics Ltd
Chirascan Plus Spectrometer (Leatherhead, UK).
Rectangular Suprasil cells with 1-cm path lengths were
employed to record spectra in the regions between 340
and 220 nm. The parameters used to acquire the spectra
were: spectral bandwidth of 1 nm, data step-size of 1 nm
with a time-per-data-point of 1.5 s. Spectra were baseline
corrected by subtracting the spectrum of the buffer alone.
In all the experiments the protein concentration was in the
range of 0.1–0.2mg/ml (3.6–9 mM) and the RNA
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concentration was between 6 and 10 mM. The CD spectra
of the protein-containing samples were acquired in 20mM
Tris, 100mM KCl, 1mM DTT, pH 7.25. Thermal unfold-
ing curves of domain IV, IVhalves, IVlowerSL, IV30ext, IV50ext
and 22-mer structRNA were recorded in the temperature
mode monitoring the change of the signal at 260 nm from
5 to 95C with a heating rate of 1.0C/min. For melting
experiments, RNA concentrations of 6 mM were used, in
two different buffers, 20mM Tris, 100mM KCl pH 7.25;
and 20mM Tris, 100mM KCl, 10mM MgCl2 pH 7.25.
Electrophoretic mobility shift assays
La proteins were incubated for 15min at room tempera-
ture with 100 nM g-32P end-labelled RNA in 20 ml binding
reactions in 100mM NaCl, 10mM Tris, 5mM EDTA pH
8 before loading onto a native 12% polyacrylamide gel.
Gels were run at 35mA for 2.5 h in 1 TAE, dried and
autoradiographed.
RESULTS
Identiﬁcation of the regions of hLa involved in domain IV
HCV RNA interaction
The human La protein has been shown to bind to domain
IV of the HCV IRES RNA (nucleotides 330–356, Figure 1,
hereafter referred to as IV), yet the domains of La re-
sponsible for this interaction have not been thoroughly
investigated. A number of deletion mutants of hLa were
therefore designed, prepared and tested for domain IV
RNA binding: La(1–408) (full-length); La(1–354)
(spanning the three structured domains and the SBM);
La(4–325) (spanning the La module and the RRM2);
La(1–229) (spanning the La module and the interdomain
linker between RRM1 and RRM2); La(1–194) (spanning
the La module); La(105–325) (spanning the two RRMs)
(Figure 1). Electrophoretic mobility shift assays (EMSA)
showed that La(1–408) binds to domain IV to form a
single, well-deﬁned complex, and that progressively
trimming the C-terminus up to residue 325 had no ob-
servable impact on the afﬁnity of the protein for domain
IV RNA (Figure 2). Further deletions, to remove RRM2
in La(1–229) or La(1–194) or the LaM in La(105–325),
resulted in a marked loss of binding afﬁnity (Figure 2
and data not shown). Moreover, none of the individual
domains (LaM, RRM1 and RRM2) exhibited binding
capability for domain IV (data not shown).
Thus, the deletion mutant La(4–325), comprising the
three structured domains of hLa, appears to contain the
minimum set of domains required to bind to domain IV of
HCV RNA. Intriguingly, this differs from the 30 oligoU
ssRNA recognition that is conﬁned to the La module
La(1–194), thereby pointing to an alternative mechanism
of recognition by hLa for structured RNA sequences that
lack a 30 UUUOH.
Addition of molar excesses of ssRNA oligos (10- to
48-nt long that did not contain 30 oligoU sequences)
used as competitor ligands in EMSA experiments had
only a minor effect on binding. In contrast, it is intriguing
to note that the formation of La-domain IV RNA
complexes was efﬁciently inhibited by a subset of
structured RNA sequences and by 30 oligoU ssRNAs
(see below and data not shown).
hLa-domain IV interaction involves a distinct recognition
mechanism
To provide quantitative detail on how the interaction
of La with domain IV differs from the 30 oligoU
ssRNA recognition, we performed ITC measurements.
Figure 2. Interaction of the human La protein with domain IV of the HCV IRES. (A) Representative EMSA experiment of domain IV RNA
(20 nM) mixed with two different concentrations (0.5 and 2.0 mM) of the following proteins: full-length La(1–408), La(1–354), La(4–325), La(1–194)
and La(105–325). (B, C, D, E) ITC experiments of the interaction of domain IV RNA with La(1–194), La(1–229), La(4–325) and La(1–408)
respectively. The normalized heat of interaction for the titrations was obtained by integrating the raw data and subtracting the heat of ligand
dilution into the buffer alone. The grey line represents the best ﬁt obtained by a non-linear least-squares procedure based on an independent binding
sites model. Dissociation constants (Kd) are shown for each interaction. The binding proﬁle observed for the full-length protein is unchanged in the
mutant La(4–325), but a dramatic decrease in binding afﬁnity is observed for mutants lacking RRM2. (F, G, H, I) ITC experiments of the interaction
of UUUUOH RNA with La(1–194), La(1–229), La(4–325) and La(1–408). All the proteins show similar afﬁnities and thermodynamic proﬁles for the
interaction with this RNA, conﬁrming that La(1–194) is sufﬁcient for binding to short 30 U-rich RNA sequences.
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This technique has the advantage of affording more precise
measurements of the afﬁnity constants while simultan-
eously revealing the stoichiometry and the thermodynamic
signature of binding interactions, which can provide useful
mechanistic clues. Two sets of experiments were carried
out, titrating La(1–408) and deletion mutants La(1–194),
La(1–229) and La(4–325) with 4-nt oligoU and HCV
IRES domain IV, respectively (Figure 2 and Table 1).
The binding of hLa mutants to UUUUOH RNA
adheres closely to the interaction proﬁle expected from
previous work (9,13,27), with the La module La(1–194)
solely in charge of the recognition (Table 1 and Figure 2).
Consistent with this idea, the enthalpic and entropic con-
tributions to binding are broadly similar for La(1–194)
and the full-length La(1–408).
In agreement with the EMSA results, ITC experiments
conﬁrmed speciﬁc binding of full-length hLa to domain IV
of HCV IRES, in that this association generated a well
interpolated sigmoid-shaped curve based on an independ-
ent and equivalent binding sites model centred on a 1:1
stoichiometry, indicative of the formation of a unique
complex with deﬁnite intermolecular interactions and
deﬁned energetics of association (41,42). The binding
afﬁnity is 7-fold lower than that for UUUUOH RNA
(Kd=3.7 mM), under the experimental conditions used
(Figure 2 and Table 1). Comparison of the thermodynam-
ic binding parameters revealed that La(4–325) behaved
essentially as the full-length protein with respect to
domain IV recognition, whereas removal of RRM2 [in
the deletion mutants La(1–229) and La(1–194)] was
accompanied by a substantial decrease in binding
afﬁnity and a markedly different thermodynamic signa-
ture of the molecular association, in which the magnitudes
of the enthalpic and entropic contributions were signiﬁ-
cantly reduced, as well as the binding stoichiometry
(Figure 2 and Table 1).
The association of hLa with oligoU and domain IV at
25C is enthalpically driven with an unfavourable entropic
contribution in both cases, although the thermodynamic
signatures of binding are not identical: binding of hLa to
HCV IRES domain IV involves smaller changes in
enthalpy and entropy (Table 1). ITC was also used to
examine the perturbations of the binding energetics of
La(4–325) for both RNA ligands by varying concentra-
tions of MgCl2 (0–10mM) or KCl (100–200mM). In
agreement with previous reports (16), the interaction of
La with 30 UUUOH RNA was found to be Mg
2+-inde-
pendent while reduction of Mg2+ concentration from 10
to 0mM produced a 7-fold enhancement of binding
afﬁnity for La(4–325)-domain IV association (Table 1).
Furthermore, a very different dependence on KCl concen-
tration was observed for the two interactions (Table 1).
These results show two distinct and diverse modes of
RNA binding by the La protein: (i) the well-known
sequence-speciﬁc 30 oligoU recognition supported exclu-
sively by the La module and relatively unresponsive to
changes in buffer ionic strength; and (ii) the newly
characterized interaction with domain IV of HCV IRES
(which lacks a 30 oligoU element) that requires the La
module and the RRM2 and has exposed, for the ﬁrst
time, a requirement for RRM2 domain to RNA binding.
Data also suggest that the electrostatic contribution is
likely to play a more substantial role in binding of hLa
to domain IV than in its interaction with 30 oligoU RNA,
underscoring the differences in the mechanisms of recog-
nition by hLa protein.
Domain IV adopts a stem–loop conformation
Which particular features of domain IV RNA are being
recognized by the La protein in this novel mode of
binding? As depicted in Figure 1C, the 27-nt fragment
containing the HCV IRES domain IV is predicted by
mfold (43) to form a stem–loop structure (with a 5-bp
lower stem and a 7-nt loop), topped by a small bulge, a
short 2-bp upper stem and short 50 and 30 extensions. As
no detailed structural information is available on this
IRES domain to date, the mfold prediction was scrutinized
by CD and NMR spectroscopy.
The CD spectrum of domain IV at 25C indicated that
the RNA duplexes adopt an A-conformation, with a large
Table 1. Thermodynamic parameters of the association of the human
La protein and mutants thereof with different RNA targets in
standard conditions (20mM Tris, 100mM KCl, 10mM MgCl2,
1mM DTT, pH 7.25)
n Kd
(mM)
H
(kJ/mol)
–TS
(kJ/mol)
G
(kJ/mol)
La(1–194)/UUUU 1.0 0.30 149 112 37
La(1–229)/UUUU 0.9 0.30 170 133 37
La(4–325)/UUUU 0.9 0.30 150 113 37
La(1–408)/UUUU 1.0 0.49 179 143 36
La(1–194)/IV 0.4 50 42 18 24
La(1–229)/IV 0.4 45 45 20 25
La(4–325)/IV 0.9 3.7 93 62 31
La(1–408)/IV 0.9 3.7 102 71 31
La(4–325)/IVMet 0.9 5.5 101 71 30
La(4–325)/IVhalves 0.9 3.7 68 37 31
La(4–325)/IV30ext 0.9 1.4 68 35 33
La(4–325)/IV50ext 0.9 1.0 64 30 34
La(4–325)/IVlowerSL 0.4 43 50 25 25
La(4–325)/22-mer
structRNA
0.9 1.6 72 39 33
La(1–194)/IVUUUU 0.9 0.73 209 174 35
La(4–325)/IVUUUU 0.9 0.73 251 216 35
27-mer ssRNA/ La(4–325) – – – – –
In absence of MgCl2 (20mM Tris, 100mM KCl, 1mM DTT,
pH 7.25)
La(4–325)/UUUU 0.9 0.49 185 149 36
La(4–325)/IV 0.9 0.48 121 85 36
In absence of MgCl2 and varying KCl concentrations
La(4–325)/UUUU
(115mM KCl)
0.9 0.52 179 143 36
La(4–325)/UUUU
(150mM KCl)
0.8 0.55 175 139 36
La(4–325)/UUUU
(200mM KCl)
0.9 0.59 167 131 36
La(4–325)/IV
(115mM KCl)
0.9 0.50 100 64 36
La(4–325)/IV
(150mM KCl)
0.8 0.56 92 57 35
La(4–325)/IV
(200mM KCl)
0.8 0.62 71 36 35
The values reported are averaged over three different experiments, and
the errors in the thermodynamic parameters are <5%
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positive band 260 nm and a large negative signal at
210 nm (44,45) (Supplementary Figure S1). The CD mag-
nitude at 260 nm was followed in CD melting experiments,
performed by heating the RNA samples from 5C to 95C
and intended to inform on the veracity of the predicted
secondary structure in conjunction with deletion mutagen-
esis. Under these conditions and in standard buffer,
domain IV unfolds with two major apparent transitions
with melting temperatures (Tm) of 40
C and 78C
(Supplementary Figure S1). Removal of the 2-bp upper
stem in IV30ext, IV50ext and IVlowerSL variants affected the
transition at 40C but left the higher temperature transi-
tion largely unchanged (Supplementary Figure S1),
thereby tentatively assigning the opening of the upper
stem to the ﬁrst and the unfolding of the lower stem to
the second apparent transition. Elimination of MgCl2
from the buffer did not alter the shape of the melting
curve for domain IV RNA but resulted in a shift of Tm
for both transitions (to 30C and 70C respectively)
(Supplementary Figure S1).
NMR experiments conducted on domain IV were also
consistent with the mfold predicted secondary structure
and CD melting proﬁles. In particular, the 1H NMR
spectrum conﬁrmed the presence of 6 or 7 resonances cor-
responding to base-paired imino protons, two of which at
25C were only visible (albeit as broad signals) in the
presence of 10mM MgCl2 (data not shown).
Although in absence of structural data alternative inter-
pretations of the CD melting curves are still possible, these
analyses appear to be consistent with the mfold predicted
secondary structure arrangement of domain IV. This
provided a framework for designing mutants to be tested
for protein recognition.
Identiﬁcation of RNA elements within HCV IRES domain
IV recognized by hLa
In order to identify the elements within domain IV that
are involved in its interaction with the hLa protein, a
number of RNA variants (Figure 3) were constructed
and their ability to bind La(4–325) determined by ITC.
The mutants included:
1. Modiﬁcation to block 30-OH group
2. Mutations to destroy duplex formation
3. Mutation to interfere with lower loop
4. Mutations at the bulge and upper stem.
In each case, correct folding of the variant RNAs was
veriﬁed by CD spectroscopy (see above and
Supplementary Figure S1).
1. The 30-OH of the HCV domain IV is not involved in
binding hLa. Since domain IV of the HCV IRES
domain is an ‘internal’ sequence embedded within the
50-UTR of the viral genome, it was imperative to verify
that its association with La would not hinge on the free
30-OH artiﬁcially created in the truncated RNAs used in
our biophysical measurements. To this end, a 30
O-methylated version of domain IV (IVOMe) was
synthesized and its association with La(4–325) examined,
conﬁrming a binding proﬁle analogous to the 30-OH coun-
terpart (Figure 3B). In marked contrast, the same
chemical modiﬁcation of a 30 UUUOH ligand resulted in
a 38-fold reduction of binding afﬁnity (12). The loss of
discrimination for the 30-OH denotes that the interaction
between La and domain IV is a genuine ‘internal’ mode of
binding which, contrary to oligoU sequences, is independ-
ent from 30 termini recognition.
2. The RNA duplex is necessary for binding. Next, we
asked whether the double-strand structure in domain IV
is essential for interaction with La(4–325). To address this,
we introduced a number ofG or A toC substitutions within
the RNA that would disrupt existing base pairings and
prevent formation of any other stable duplex, thereby
generating a predominantly ss 27-nt RNA (27-mer
ssRNA, Figure 3G and Supplementary Figure S1). This
resulted in complete abrogation of binding, suggesting
that a double-stranded structure, either in isolation or
within a stem–loop moiety, may be a feature recognized
by the hLa protein.
3. The lower loop of the HCV RNA plays no role in hLa
recognition. Loops of 7–15 nt located in the context of
RNA hairpin structures have been shown to be interacting
partners of single or tandem RRM containing proteins
(46–49). To gauge the role of domain IV lower loop in
La recognition, a cleavage in the phosphate backbone was
effectively introduced between the third and fourth loop
nucleotides by re-constructing domain IV from two par-
tially complementary fragments (in the mutant hereafter
referred to as IVhalves). As this modiﬁcation had virtually
no effect on the binding afﬁnity for La(4–325) (Figure 3C),
we conclude that an intact lower loop is not implicated
in the interaction with hLa. This was further conﬁrmed
by the experiments with the 22-mer structRNA (see
below).
4. 30 or 50 ss extensions are key determinants for hLa
recognition. The mutants IV50ext, IV30ext and IVlowerSL
(Figure 3D–F) were designed to dissect the contributions
to La binding of the bulge, upper stem and 50/30 extensions
of the RNA. Deletion of all these elements in IVlowerSL
generated an unadorned hairpin-loop structure which
bound an order of magnitude more weakly to La(4–325)
than the intact domain IV (Figure 3D). Interestingly, the
addition of a ss extension at the 50 or 30 end of the lower
stem–loop (in the IV50ext and IV30ext mutants respectively)
completely restored high-afﬁnity binding to La(4–325). In
fact, these RNAs even displayed a slightly enhanced
afﬁnity compared to domain IV (Figure 3A, E, F and
Table 1).
Taken together, these experiments suggest that the
minimal element of domain IV required for La interaction
encompasses the lower stem ﬂanked by a ss extension on
either the 50 or 30 end.
hLa–domain IV RNA interaction is a shape-directed
recognition
The analysis of the binding requirements acquired thus far
points towards shape-dependent rather than a
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sequence-speciﬁc type of recognition. To further support
this hypothesis, we repeated ITC and EMSA experiments
with an RNA molecule that would retain the key struc-
tural features of the domain IV—a duplex stem with ss 50
and 30 extensions—but with a completely different nucleo-
tide sequence as well as a shorter lower loop (22-mer
structRNA, Figure 3H and Supplementary Figure S1).
ITC experiments conﬁrmed that La(4–325) binds to
22-mer structRNA with an afﬁnity and overall thermo-
dynamic parameters that are closely comparable to
domain IV, indicative that in both cases the interaction
follows a similar mechanism of recognition (Figure 3).
These data therefore endorse a shape-dependent mech-
anism of recognition, in contrast to the sequence-speciﬁc
30 oligoU interaction. While hLa may make a number of
hydrogen bonding and stacking ‘cation-p’ interactions
with domain IV RNA, shape-selective recognition
probably mainly occurs through contacts with the
sugar–phosphate backbone, since, as shown by ITC meas-
urements, the interaction is salt sensitive and therefore
involves a signiﬁcant electrostatic component (Table 1).
Domain IV undergoes minor conformational
changes upon La binding
Next we examined the inﬂuence of La binding on the con-
formation of domain IV, as other IRES-binding proteins
are known to induce conformational changes in their
RNA targets with consequent enhancement of IRES
function (50). Moreover, hLa itself has recently been
shown to harbour both strand-annealing and strand-
dissociation RNA chaperone capabilities (A.R. Naeeni,
M.R.C. and M.A. Bayﬁeld, unpublished data).
Comparison of the near-UV CD spectra arising from
the RNA in the free and La(4–325)-bound state reveals a
modest reduction in the intensity of the RNA CD signal
Figure 3. Interaction of La(4–325) with RNA targets. (A–H) ITC experiments showing the thermal effect of mixing La(4–325) with different RNA
targets as follows: (A) IV; (B) IVOMe; (C) IVhalves; (D) IVlowerSL; (E) IV30ext; (F) IV50ext; (G) 27-mer ssRNA; (H) 22-mer structRNA. The grey lines
represent the best ﬁt derived by a non-linear least-squares procedure based on an independent binding sites model. The expected secondary structures
of the RNA molecules obtained with the software mfold, which matched well with CD thermal unfolding data (Supplementary Figure S1), are shown
beside each graph. Taken together, these data show that La(4–325) recognizes a double-stranded stem ﬂanked by extensions at the 50 or 30,
independently of nucleotide sequence.
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(at 260 nm) in the complex (Figure 4). Such a proﬁle, often
brought about by double-stranded nucleic acid binding
proteins, is indicative of a somewhat decreased stacking
of the DNA/RNA bases, and it may denote localized
melting and/or distortion of the double helix of domain
IV following La(4–325) binding (51). Although the CD
data do not allow us to elaborate on the exact nature of
this conformational rearrangement, the observed effect is
small, implying that a large portion of the double-stranded
region of domain IV would still be retained in the complex
with La(4–325). Attempts to analyse further the conform-
ation of domain IV bound to La using NMR spectroscopy
failed because of the poor linewidth of the RNA reson-
ances in the complex.
The three structured domains and both inter-domain
linkers are affected by La(4–325) binding to domain IV
The surfaces of the hLa protein involved in shape-
dependent recognition of domain IV were delineated by
NMR chemical shift perturbation analysis. To begin with,
backbone assignment for apo La(4–325) was obtained by
analysis of TROSY-based experiments on a 70% non-
exchangeable deuterated sample. For structured portions
(LaM, RRM1 and RRM2), most of the chemical shifts
were directly transferred from previously obtained assign-
ments of the individual domains (33,52–54) indicating that
these maintain essentially the same structure in the context
of the longer protein and that in solution they largely tum-
ble independently of one another. Backbone NMR assign-
ments of the linker regions connecting the structured
domains proved more challenging. Although the linker
stretch between the LaM and RRM1 had already been as-
signed in the apo La(1–194) protein (54), weak, missing
and/or severely overlapped resonances prevented their un-
ambiguous identiﬁcation in free La(4–325). No prior in-
formation was available for the 30 residue inter-RRM
segment and several residues remain unassigned
(Supplementary Figure S2C).
To identify regions of the protein affected by complex
formation, chemical shift variations experienced by
protein residues upon addition of domain IV RNA were
mapped onto the structures of the isolated domains or
annotated to inter-domain linker regions (Figure 5). This
analysis shows variations across the entire molecule, i.e. in
residues belonging to LaM, RRM1 and RRM2, as well as
the inter-RRM linker (Figure 5 and Supplementary Figure
S2C); despite the lack of resonance assignment for the
linker between the LaM and RRM1 in La(4–325)
spectra, the experiments performed on La(1–194)
described below suggest that this region is also affected
by domain IV complex formation.
The majority of the strong chemical shift changes are
spread over the LaM and RRM1, and the patches thereby
delineated overlap to some degree with the surfaces
involved in 30 oligoU recognition, especially for the
former domain (Figure 5). Nonetheless, intriguing differ-
ences emerge with respect to the RRM1: in particular,
while the titration with UUUUOH leaves the a1/a2 face
of this domain completely devoid of perturbations,
binding of IRES domain IV is sensed by several residues
clustered on this ‘hind’ region (Figure 5). However it
remains unclear whether this identiﬁes a potentially new
RNA-binding surface on RRM1 or reﬂects conformation-
al changes on binding that are propagated to the helical
face of RRM1.
In accord with our EMSA and ITC results, NMR
chemical shift variations were also detected in regions of
the protein beyond the La module, in particular affecting
the RRM2 and the inter-RRM linker, although the asso-
ciated shifts appear to be less pronounced. Intriguingly,
the observed perturbations on the RRM2 do not map to
the canonical b-platform RNA-binding surface, but rather
interest part of the atypical C-terminal a-helix that in this
domain lies across the upper part of the b-sheet (27).
Assuming that domain IV binding elicits conformational
rearrangements of the modular structured domains of the
protein, it is likely that the chemical shift variations
experienced by the inter-RRM linker are coupled with
induced conformational changes, although the possibility
of a direct contact with RNA cannot be ruled out.
HCV IRES domain IV binding by hLa involves
a bipartite mode of recognition
Given that the La module is a ssRNA-binding unit (13)
and strengthened by our observations that many of the
surfaces mediating 30 oligoU interaction also appear to
be involved in the interaction with domain IV, we
speculated that this portion of the protein would be impli-
cated mainly in contacting the ss stretches of domain IV,
with the rest of the molecule engaging the double-stranded
Figure 4. CD analysis of domain IV conformation upon interaction
with La. (A) Near-UV CD spectra of domain IV RNA alone (dotted
line) and in complex with the La(4–325) (grey line) show a modest
reduction in the intensity of the CD signal at 263 nm following
protein binding. Since the signal from the RNA dominates the CD
spectrum at wavelengths >250 nm (near UV), with the signal of the
protein being negligible in this range (black line), any spectral differ-
ence here could therefore be attributed solely to changes in the poly-
nucleotide conformation. (B) Near-UV CD spectra of domain IV RNA
alone (dotted line) and in complex with the La(1–194) (grey line). In
this case a much smaller change in the RNA CD signal was detected.
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element. To test this hypothesis, we analysed the NMR
chemical shift variations generated by titrating domain IV
into a sample containing 15N-labelled La(1–194).
Although ITC and EMSA experiments showed that
La(1–194) did not possess all the determinants to behave
as the full-length protein with respect to domain IV
binding, NMR experiments carried at millimolar concen-
trations could be used to investigate lower afﬁnity inter-
actions. Intriguingly, the chemical shift variations
experienced by La(1–194) upon addition of domain IV
were almost completely superposable on the shifts
observed in this part of the protein in the context of the
longer La(4–325) (Supplementary Figure S2B).
Furthermore, a similar result (albeit with some variations
in the shift proﬁle) was obtained by titrating a single
strand of IVhalves (data not shown), endorsing a model
in which the La module is responsible for making
contacts with a ss portion of IV RNA, whereas the
inter-RRM linker and RRM2 are important for dsRNA
interaction.
Finally here, the higher quality NMR spectra obtained
with the smaller La(1–194) protein indicated that the
linker between the LaM and RRM1 experienced
chemical shift variations upon domain IV titration,
Figure 5. NMR analysis of La-domain IV interaction. (A) Structure mapping of the chemical shift variations obtained in La(4–325) on domain IV
binding for the LaM, RRM1, RRM2 and inter-domain linkers and comparison with the electrostatic surface potential. The LaM, RRM1 and RRM2
are shown as structures of individual domains (PDB ID: 1S7A, 1S79 and 1OWX respectively), whereas the inter-domain linkers are shown as bars
between domains. The positions of the residues that show substantial shifts are indicated on the protein secondary structures (top) and surfaces
(middle). The chemical shift perturbations (dAV) are represented with the following colour code: yellow (0.035dAV 0.06), orange
(0.06<dAV 0.1), red (dAV> 0.1), pink (disappearing signals) and magenta (not quantiﬁed) (Supplementary Figure S2C). (B) Structure
mapping of the chemical shift variations obtained in La(1–194) on 30 oligoU binding for the LaM, RRM1 and inter-domain linker.
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probably more as a result of conformational changes than
direct contacts with RNA, as observed before for 30
oligoU RNAs (12,13). Since most of the other resonances
in La(1–194) complexed with domain IV could be directly
transferred onto the spectra of La(4–325)–domain IV, we
assume that this linker also changes in the context of the
longer protein.
Comparison between domain IV binding and pre-tRNA
type of interaction
On the basis of the proposed bipartite model of interaction
we were intrigued to know whether the mode of inter-
action revealed for the La-domain IV complex—recogni-
tion of a stem bordered by a ss extension—might also
apply for pol III nascent transcripts, where the ss tail
would terminate with a 30 oligoU sequence. To address
this, we constructed an RNA mutant that bears the
lower stem of domain IV appended to a 30 UUUOH
trailer, termed IVUUUU, and monitored its interaction
with La(1–194) and La(4–325) by ITC. Figure 6 shows
that La(1–194) and La(4–325) bind IVUUUU with indistin-
guishable thermodynamic signatures of association which
are somewhat reminiscent of the ss oligoU interaction
proﬁle (Figure 6). In other words, for this small structured
RNA mutant that harbours a 30 oligoU end, all the deter-
minants for interaction seemingly reside within the La
module La(1–194), and no clear evidence for an additional
contribution to binding by the RRM2 and inter-RRM
linker (perhaps to the stem region) could be seen in the
longer La(4–325). We deduce that the interactions of La
with domain IV (short double-stranded stem ﬂanked by a
short single-strand extension) and structured 30 oligoU
containing RNA targets appear to be mutually exclusive
(see ‘Discussion’ section).
DISCUSSION
While a large number of reports designate hLa as an es-
tablished IRES trans-acting factor (18–26,28,55,56), a
rigorous analysis of the mechanism underpinning the rec-
ognition of these internal RNA sequences by La has been
lacking. The study presented here detailing the interaction
of hLa with domain IV of the HCV IRES provides im-
portant new insights into this mode of binding and so into
the adaptability of the La protein in recognizing
structured RNA targets that lack a 30 oligoU element.
We performed a systematic biophysical investigation
closely informed by the structure of human La to
provide evidence that the protein binds HCV IRES
domain IV using an alternative mode of RNA recognition
that differs markedly from its well-characterized inter-
action with 30 UUUOH ssRNAs. Several attributes distin-
guish the two mechanisms: whereas recognition of 30
oligoU sequences is directed by an exposed 30 end, a
speciﬁc nucleotide sequence and a ssRNA conformation,
the interaction with domain IV is truly ‘internal’, selecting
for particular RNA structural motifs (short duplexes with
single-stranded trailers) but independent of nucleotide
sequence composition.
Our results provide a molecular explanation of how the
human La protein can effectively handle such profoundly
different modes of RNA recognition, in that it relies ex-
clusively on the La module for the 30-termini binding but
summons the three modular domains for the internal type
of recognition. Remarkably, while the La module appears
precisely tailored to recognize a free 30-OH and the pen-
ultimate uridine base (U-2) in 3
0 oligoU RNA sequences
(12,13), in conjunction with the inter-RRM linker and
RRM2 it can bind with comparable afﬁnity to radically
different RNA targets, using a mode of binding that alle-
viates the dependence of 30 termini recognition. These
Figure 6. Comparative analysis of the interaction between La and IVUUUU RNA. (A) Sequence and secondary structure for IVUUUU, which retains
the lower stem–loop portion of domain IV while the 50 and 30 extensions are mutated to oligoC and oligoU, respectively. (B and E) ITC experiments
examining the interaction of IVUUUU with La(4–325) and La(1–194) respectively. The grey line represents the best ﬁt obtained by a non-linear
least-squares procedure based on an independent binding sites model. For comparison, the interactions of domain IV (C and F) and UUUUOH (D
and G) with La(4–325) and La(1–194) respectively are reported. For the interactions of La(4–325) and La(1–194) with IVUUUU, the thermodynamic
signature of binding, evaluated as the relative H/–TS value, is identical in both cases and is closer to the UUUUOH associations (Table 1).
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ﬁndings signiﬁcantly extend the known plasticity of La–
RNA interactions (13,14).
Interestingly, our experiments with the variant IVUUUU
RNA suggest a mutually exclusive behaviour for the 30
UUUOH versus the internal type of RNA recognition. In
particular, since no difference could be detected in the
binding of IVUUUU to La(4–325) and La(1–194), it
appears that the clamping onto the intervening 30 ss
oligoU stretch within IVUUUU by the La module renders
it incapable of working together with the RRM2 and
inter-RRM linker to generate the composite RNA-
binding surface required for contacting the double-
stranded portion of IVUUUU. Given that binding of the
La module to UUUOH dictates a precise orientation of
both protein and RNA through formation of the speciﬁc
RNA-binding cleft and coordination of the 20 and 30 hy-
droxyls by D33 (13), it may be conceivable to invoke in-
compatibility between this imposed geometry and the
simultaneous rearrangement of the three modular domains
underlying the alternative mode of RNA binding.
Whatever the precise molecular basis of the competition
between the two modes of interaction, the dominance of 30
oligoU binding, which is mediated only by the La module,
provides a ready explanation for the fact that the possible
contribution of RRM2 binding to structured RNAs con-
taining a 30 oligoU tail, such as pre-tRNAs, has not been
detected in previous work (16,17). Nevertheless, although
our results suggest that RRM2 is not involved in binding
IVUUUU, it is possible that for larger RNA targets binding
to a 30 oligoU tail by the La module would not preclude
involvement of RRM2 in contacting other, perhaps more
distal, parts of the RNA.
Indeed, the interest in the alternative mechanism of
binding by La is heightened by the fact that for the ﬁrst
time a clear contribution of RRM2 to RNA binding has
been revealed by a systematic study based on the known
structure of the domain (27). Intriguingly, chemical shift
analysis suggests that the RRM2 does not behave as an
ordinary RRM: ﬁrst, the canonical b-sheet RNA-binding
surface appears unaffected by the presence of domain IV;
second, NMR data indicate that the RRM2 largely retains
its free form conformation in the complex, implying that
the b-sheet platform will remain in part blocked by the
long C-terminal helix (27); third, such an atypical helix
may itself be a feature for domain IV recognition. NMR
analysis also highlights the unexpected involvement of the
a1/a2 helical face of the RRM1 in complex formation. In
this scenario, our proposed bipartite model posits that the
La module interacts with the single-stranded extension of
domain IV, with the rest of the protein involved in con-
tacting the double-stranded portion of the RNA
(Supplementary Figure S3). Intriguingly, the 50/30 direc-
tion of the ss extension appears not to be critical for La
binding, perhaps suggesting a degree of ﬂexibility for the
contacts with the backbone of this region.
Veriﬁcation of this model and elucidation of the ar-
rangement of the RNA-binding domains within the
La–domain IV complex awaits a full structure
determination.
Nevertheless, our work assigns a clear molecular role to
the C-terminal region of hLa in HCV IRES domain IV
recognition, and builds on past functional studies
(2,19,21,22) to provide a solid framework to investigate
how hLa contributes to IRES-directed translation initi-
ation. Moreover, the essential features of the alternative
mode of RNA recognition unveiled here may hold true for
other La proteins given their resemblance across higher
eukaryotes, though will not be shared by yeast homo-
logues that do not harbour an RRM2. It appears therefore
that some of the key RNA-binding activities of La are a
prerogative of higher eukaryotes and for the ﬁrst time a
molecular explanation for the different RNA recognition
properties of the human and yeast La proteins is unam-
biguously provided. Our observations not only suggest
plausible solutions for some of the conﬂicting results
observed in the past decade regarding additional roles of
La (e.g. modulation of removal of pre-tRNA 50 trailers,
nuclear retention of certain transcripts, stabilization of
viral mRNA) (1), but also offers new insights for a
sounder appreciation of the functional difference between
the La proteins across species.
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